Green Planet Bioengineering Co Overview
Get informed when a big investor buys or sells
+ Follow8.06%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for GPLB is 8.06%. That is below the sector sector average of 11.64%. Investors often review this figure alongside Green Planet Bioengineering Co's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, GPLB currently prints 8.06% for ROE, while the sector average sits near 11.64%. That is roughly 30.7% below the sector mean. Large gaps often invite a closer look at Green Planet Bioengineering Co's growth, margins, and balance sheet.
Return on Equity shows how effectively Green Planet Bioengineering Co converts resources into returns. At 8.06%, GPLB may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GPLB's ROE (8.06%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
